Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
32.5M
-
Shares change
-
+5.71M
-
Total reported value, excl. options
-
$162M
-
Value change
-
+$30.1M
-
Put/Call ratio
-
1.59
-
Number of buys
-
56
-
Number of sells
-
-49
-
Price
-
$4.97
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q3 2022
146 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q3 2022.
ImmunityBio, Inc. - COM (IBRX) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.5M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (8.08M shares), STATE STREET CORP (6.65M shares), GEODE CAPITAL MANAGEMENT, LLC (1.92M shares), JPMORGAN CHASE & CO (1.56M shares), NORTHERN TRUST CORP (811K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (712K shares), ALLEN HOLDING INC /NY (688K shares), D. E. Shaw & Co., Inc. (679K shares), MORGAN STANLEY (642K shares), and PICTET ASSET MANAGEMENT SA (638K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.